Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry.

Yuka Sugawara Masao IwagamiKan KikuchiToyohiro HashibaSayaka YabushitaMunekazu RyuzakiMasaomi Nangaku

Published in: Nephrology (Carlton, Vic.) (2024)

In Japanese patients undergoing haemodialysis, the first or second COVID-19 vaccine dose was significantly associated with decreased COVID-19 infection and mortality rates, suggesting its effectiveness in this population.

Keyphrases

coronavirus disease
patients undergoing
randomized controlled trial
end stage renal disease
systematic review
chronic kidney disease
respiratory syndrome coronavirus
sars cov
peritoneal dialysis
cardiovascular events
risk factors
coronary artery disease